Advanced Parenteral Drug Delivery Devices Market Analysis - Global Industry Size, Share, Trends and Forecast, 2014 - 2024

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC183

Drug delivery devices enable pharmaceutical manufacturers to differentiate their new drugs from already existing products, thereby providing ways for extending patent protection, as well as discover novel treatments. Parenteral drug administration is among the most common route of drug delivery and the major advantage associated with it is high bioavailability of the active pharmaceutical ingredient. Currently, parenteral drug delivery devices constitute the major share of the global drug delivery devices market.

Factors such as increasing usherance of novel biological products and biosimilar are leading to the development of advanced parenteral drug delivery devices for effective delivery of these products. In the drug market, polymer-encapsulated medicines, hormones and central nervous system agents are gaining importance that further requires parenteral drug delivery. Also, wide availability of pen injectors, IV catheters, vial bag infusion systems and retractable pre-fillable syringes will lead to increased market share of these parenteral drug delivery devices as they provide advantages of infection prevention.

The increasing prevalence of chronic disorders such as diabetes, cardiovascular diseases and cancer, growing demand for self-administration and home healthcare devices; the rising incidence of chronic diseases such as cardiovascular diseases, diabetes, and cancer; the growing focus on pediatric and geriatric patients; and the increasing demand for minimally invasive surgeries are other factors contributing to growth in the drug delivery market. In addition, pharmaceutical companies are increasingly adopting drug delivery technologies to differentiate their products in the highly competitive environment.

The global advanced parenteral drug delivery devices market is segmented by applications, products, and geography. On the basis of products, the global advanced parenteral drug delivery devices market is classified into IV catheters, pre-fillable syringes, hypodermic syringes, injector cartridges, and other parenteral delivery devices. In addition, on the basis of applications, the global advanced parenteral drug delivery devices market is bifurcated as central nervous system agents, hormones & related agents, respiratory agents, gastrointestinal agents, anti-infective agents, cardiovascular agents, genito-urinary agents, and nutritional agents.

The global advanced parenteral drug delivery devices market is segmented by region into Asia-Pacific (APAC), Europe, North America, Latin America, and Middle East and Africa. Factors such as increasing usherance of novel biological products and biosimilar are leading to the development of advanced parenteral drug delivery devices for effective delivery of these products. Also, wide availability of pen injectors, IV catheters, vial bag infusion systems and retractable pre-fillable syringes will lead to the increased market share of these parenteral drug delivery devices as they provide advantages of infection prevention.

North America is analyzed to possess the largest market share in terms of revenue owing to the rising patient awareness levels and increasing acceptance and adoption of high-tech healthcare systems. On the other hand, the European market trails the North American market in terms of revenue, owing to increasing acceptance and adoption of high-tech healthcare systems. The global advanced parenteral drug delivery devices market in Asia-Pacific is analyzed to be the most lucrative market owing to the increasing penetration of advanced healthcare technology and products, and rapidly improving healthcare infrastructure in emerging economies of India and China. Thus, the Asia-Pacific region serves as a great untapped opportunity for key market players in this industry.

The global advanced parenteral drug delivery devices market is highly competitive with respect to pricing and technological advancements. A few of the key players dominating the global advanced parenteral drug delivery devices market include Abbott Laboratories, AptarGroup Incorporated, Amgen Incorporated, AstraZeneca plc, Becton, Dickinson and Company, Baxter International Incorporated, Boston Scientific Corporation, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Novartis AG, Roche Holding Limited, and Pfizer Incorporated, among others.


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary